Literature DB >> 24106751

Omentoplasty to assist perineal defect closure following laparoscopic abdominoperineal resection.

S Killeen1, M Mannion, A Devaney, D C Winter.   

Abstract

AIM: This technical note describes laparoscopic production of a well vascularized, omental flap of adequate size to fill the pelvic floor defect in the course of laparoscopic abdominoperineal resection (LAPR).
METHOD: The omentum is laparoscopically mobilized and transposed to the pelvis following full LAPR in three discrete stages.
RESULTS: Laparoscopic omental mobilization, transfer and buttressing of a primary perineal repair reduces pelvic dead space and facilitates closure following LAPR with minimal additional operative time or complications and a potential reduction in perineal wound associated morbidity.
CONCLUSION: Laparoscopic omental mobilization is technically feasible and provides a safe method to aid perineal wound closure. Colorectal Disease
© 2013 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Omentoplasty; abdominoperineal resection; laparoscopy

Mesh:

Year:  2013        PMID: 24106751     DOI: 10.1111/codi.12426

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  3 in total

Review 1.  The future of stem cell therapy in hernia and abdominal wall repair.

Authors:  A H Petter-Puchner; R H Fortelny; S Gruber-Blum; H Redl; U Dietz
Journal:  Hernia       Date:  2014-08-14       Impact factor: 4.739

2.  The application of incisional negative pressure wound therapy for perineal wounds: A systematic review.

Authors:  Caitlin Cahill; Amanda Fowler; Lara J Williams
Journal:  Int Wound J       Date:  2018-06-04       Impact factor: 3.315

3.  Optimizing omentoplasty for management of chronic pelvic sepsis by intra-operative fluorescence angiography: a comparative cohort study.

Authors:  M D Slooter; R D Blok; M A de Krom; C J Buskens; W A Bemelman; P J Tanis; R Hompes
Journal:  Colorectal Dis       Date:  2020-08-17       Impact factor: 3.917

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.